Oncology Legal Navigation Study
Oncology Legal Navigation- Medical Legal Partnership
1 other identifier
interventional
60
1 country
1
Brief Summary
The overall objective of this study is to implement a sustainable oncology legal navigation program that will provide direct legal navigation services to help patients and caregivers overcome legal barriers to care in order to reduce cancer-related financial toxicity (FT) and improve health-related quality of life (QOL) among patients/caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 24, 2025
CompletedFirst Submitted
Initial submission to the registry
February 24, 2026
CompletedFirst Posted
Study publicly available on registry
March 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 5, 2026
March 1, 2026
1.4 years
February 24, 2026
March 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Number of participants enrolled
Feasibility was defined as 60% or higher enrolled participant retention and resolution of financial or legal issue (based on existing oncology financial navigation studies)
12 months
Acceptability assessed by 5-item survey
Acceptability is measured using a 5 item post-intervention survey of relevance, helpfulness, convenience, recommendation to others, and value. Ratings on a scale from 0 to 10 where a higher score means greater acceptability
Post intervention at 12 months
Change in Total Financial Toxicity
Measured using the COmprehensive Score for financial Toxicity (COST) tool, a measure that describes the financial distress experienced by cancer patients. Scores range from 0-44 with a higher score representing better financial well-being.
Baseline and post intervention,up to 12 months
Change in Participant Quality of Life (physical and mental)
Measured using the 10-item PROMIS® (Patient-Reported Outcomes Measurement Information System) Parent Proxy Global Health scale. A 7-item summary assessment of a child's self-reported health with higher scores representing better quality of life. Values range from 7-35, with higher scores representing better health.
Baseline and post intervention, up to 12 months
Change in Participant Quality of Life (Depression)
Measured using the 6-item Patient-Reported Outcomes Measurement Information System PROMIS® Depression Short Form. Scores range from 6 to 30. Higher scores indicate more of the construct being measured.
Baseline and post intervention, up to 12 months
Change in Participant Quality of Life (Anxiety)
Measured using the 4-item Patient-Reported Outcomes Measurement Information System PROMIS® Anxiety short form. Scores range from 4 to 20. Higher scores indicate more of the construct being measured.
Baseline and post intervention, up to 12 months
Resolution of legal Issue
Number of participants that resolved a legal or financial case as a result of the intervention
12 months
Secondary Outcomes (3)
Number of Participants Receiving Financial Benefit
12 months
Single Item Literacy Screener (SILS)
Baseline and post-intervention at 12 months
Health Insurance Literacy (HIL)
Baseline and post-intervention at 12 months
Study Arms (1)
Adult patient or caregiver of patient with cancer diagnosis
EXPERIMENTALlegal navigation program in oncology care
Interventions
Participants receive direct legal assistance/navigation followed by consultation, and assistance with legal issues related to health/social benefits, housing, employment/education, planning ahead, and family law
Eligibility Criteria
You may qualify if:
- receiving or have received services at the Markey Cancer Center, University of Kentucky
- patient with cancer diagnosis
- caregiver of patient with cancer diagnosis
- years or older
- facing legal barriers to care
You may not qualify if:
- Unable to provide consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jean Edwardlead
- University of California, Daviscollaborator
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40506, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean Edward, PhD, RN
University of Kentucky
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 24, 2026
First Posted
March 2, 2026
Study Start
March 24, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 5, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share